Company Overview and News


Add MDC
to your dashboard

Headline News

Medlab Clinical wins patent for its unique anti-depression product

2017-09-18 proactiveinvestors.com.au
Medlab Clinical Ltd (ASX:MDC) has been granted a 20-year patent covering the Australian market for its probiotic product, NRGBiotic™.

Medlab Clinical establishes strategic alliance for nutritional products

2017-07-13 proactiveinvestors.com.au
Medlab Clinical Ltd (ASX:MDC) has established a strategic alliance with Heritage Brands, to develop over-the-counter well-being solutions for the pharmacy retail channel.

Medlab Clinical to begin trials of cannabis based medicines

2017-06-19 proactiveinvestors.com.au
Medlab Clinical (ASX:MDC) has received approvals to begin human trials of two different cannabis based medicines – NanaBis and NanaBidial.

Brian Gaynor: Cannabis stocks don't take long to get high

2017-05-12 nzherald.co.nz
Global sharemarkets are going to pot as a large number of marijuana companies have listed in recent years, including on the Australian sharemarket.

Medlab Clinical initiates study of cholesterol lowering oral spray

2017-03-06 proactiveinvestors.com.au
Medlab Clinical (ASX:MDC) has signed an agreement to initiate a study to compare how its atorvastatin oral spray compares with statin tablets, like Lipitor, the off-patent market leader.

Medlab Clinical to start Australia’s first trial of cannabis for oncology patients

2017-02-22 proactiveinvestors.com.au
Medlab Clinical (ASX:MDC) is completing the final steps to start Australia’s first clinical trial using cannabis for oncology patients suffering intractable pain.

Latest Reports on Aphria, dynaCERT, Avrupa Minerals, and 92 Resources

2016-09-13 accesswire
NEW YORK, NY / ACCESSWIRE / September 13, 2016 / Canadian markets were relatively flat Monday as financials fell on retreats in overseas markets, while few energy stocks rose on an uptick in commodity prices. The S&P/TSX Composite Index gained 0.39 percent to close at 14,597.06, while the S&P/TSX Venture Composite Index gained 0.22 percent to close at 813.94. The Materials sector posted a gain of 1.

Medlab Clinical Ltd initiates Phase 2a after positive anti-depression results

2016-08-30 proactiveinvestors.com.au
Medlab Clinical Ltd (ASX:MDC) will initiate Phase 2a human trial of its anti-depression therapy following encouraging results from Phase 1. 

Medlab and Aphria Complete Cannabis Supply Deal Ahead of Cannabis Human Trial

2016-08-22 marketwired
LEAMINGTON, ONTARIO--(Marketwired - Aug. 22, 2016) - Medical life science company, Medlab Clinical Limited (ASX:MDC), has signed a significant cannabis supply agreement with Canadian licenced producer of medical marijuana, Aphria Inc. (TSX VENTURE:APH)(OTCQB:APHQF).

AusCann in medicinal cannabis alliance

2016-05-09 news.theage.com.au
JavaScript disabled. Please enable JavaScript to use My News, My Clippings, My Comments and user settings.

AusCann in medicinal cannabis alliance

2016-05-09 news.smh.com.au
JavaScript disabled. Please enable JavaScript to use My News, My Clippings, My Comments and user settings.

Appendix 4C - quarterly

2016-04-28 asx.com.au

Another cannabis company set to list

2016-03-17 news.theage.com.au
JavaScript disabled. Please enable JavaScript to use My News, My Clippings, My Comments and user settings.

Another cannabis company set to list

2016-03-17 news.smh.com.au
JavaScript disabled. Please enable JavaScript to use My News, My Clippings, My Comments and user settings.